Clinical Trials List
Protocol NumberJ2S-MC-GZME
Not yet recruiting
2025-12-01 - 2029-01-12
Phase III
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60-90 participants
-
Global
1100 participants
